These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20937008)

  • 1. Daily or monthly ibandronate prevents or restores deteriorations of bone mass, architecture, biomechanical properties and markers of bone turnover in androgen-deficient aged rats.
    De La Piedra C; Quiroga I; Montero M; Dapia S; Caeiro JR; Rubert M; Diaz-Curiel M; Bauss F
    Aging Male; 2011 Dec; 14(4):220-30. PubMed ID: 20937008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of PTH (1-84) on bone quality in a validated model of osteoporosis due to androgenic deprivation.
    Martín-Fernández M; Martínez E; Díaz-Curiel M; Guede D; Caeiro JR; De la Piedra C
    Aging Male; 2014 Mar; 17(1):42-50. PubMed ID: 23914846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats.
    Bauss F; Lalla S; Endele R; Hothorn LA
    J Rheumatol; 2002 Oct; 29(10):2200-8. PubMed ID: 12375334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial.
    Fahrleitner-Pammer A; Piswanger-Soelkner JC; Pieber TR; Obermayer-Pietsch BM; Pilz S; Dimai HP; Prenner G; Tscheliessnigg KH; Hauge E; Portugaller RH; Dobnig H
    J Bone Miner Res; 2009 Jul; 24(7):1335-44. PubMed ID: 19257824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized rats.
    Sakai S; Takeda S; Sugimoto M; Shimizu M; Shimonaka Y; Yogo K; Hashimoto J; Bauss F; Endo K
    Bone; 2015 Dec; 81():449-458. PubMed ID: 26281770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
    Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
    Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
    Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
    Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
    Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
    Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of amlodipine on rat bone tissue after orchidectomy.
    Gradosova I; Zivna H; Palicka V; Hubena S; Svejkovska K; Zivny P
    Pharmacology; 2012; 89(1-2):37-43. PubMed ID: 22302040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined treatment with ibandronate and pulsed electromagnetic field on ovariectomy-induced osteoporosis in rats.
    Zhou J; Liao Y; Xie H; Liao Y; Zeng Y; Li N; Sun G; Wu Q; Zhou G
    Bioelectromagnetics; 2017 Jan; 38(1):31-40. PubMed ID: 27711964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does exercise modify the effects of zoledronic acid on bone mass, microarchitecture, biomechanics, and turnover in ovariectomized rats?
    Lespessailles E; Jaffré C; Beaupied H; Nanyan P; Dolléans E; Benhamou CL; Courteix D
    Calcif Tissue Int; 2009 Aug; 85(2):146-57. PubMed ID: 19609736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of visceral obesity and androgens on bone: trenbolone protects against loss of femoral bone mineral density and structural strength in viscerally obese and testosterone-deficient male rats.
    Donner DG; Elliott GE; Beck BR; Forwood MR; Du Toit EF
    Osteoporos Int; 2016 Mar; 27(3):1073-1082. PubMed ID: 26438310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the effects of osteoprotegerin and testosterone on bone quality in male orchidectomised rats.
    Martín-Fernández M; Garzón-Márquez FM; Díaz-Curiel M; Prieto-Potin I; Alvarez-Galovich L; Guede D; Caeiro-Rey JR; De la Piedra C
    Aging Male; 2020 Sep; 23(3):189-201. PubMed ID: 30146916
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
    López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
    Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
    Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
    Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Morinda officinalis capsule on osteoporosis in ovariectomized rats.
    Li Y; Lü SS; Tang GY; Hou M; Tang Q; Zhang XN; Chen WH; Chen G; Xue Q; Zhang CC; Zhang JF; Chen Y; Xu XY
    Chin J Nat Med; 2014 Mar; 12(3):204-12. PubMed ID: 24702807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys.
    Smith SY; Recker RR; Hannan M; Müller R; Bauss F
    Bone; 2003 Jan; 32(1):45-55. PubMed ID: 12584035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soy protein with or without isoflavones failed to preserve bone density in gonadal hormone-deficient male rat model of osteoporosis.
    Juma SS; Ezzat-Zadeh Z; Khalil DA; Hooshmand S; Akhter M; Arjmandi BH
    Nutr Res; 2012 Sep; 32(9):694-700. PubMed ID: 23084642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.